An All-In-One Transcriptome-Based Assay to Identify Therapy-Guiding Genomic Aberrations in Nonsmall Cell Lung Cancer Patients.
Cancers (Basel)
; 12(10)2020 Oct 01.
Article
in En
| MEDLINE
| ID: mdl-33019710
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Cancers (Basel)
Year:
2020
Document type:
Article
Affiliation country:
Netherlands
Country of publication:
Switzerland